14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Jun 23, 2022 $26.30 $27.55 $25.94 $27.51 1 776 703
Jun 22, 2022 $25.36 $27.14 $25.28 $26.23 1 243 340
Jun 21, 2022 $25.75 $26.99 $25.75 $26.00 988 084
Jun 17, 2022 $24.31 $26.70 $24.13 $25.49 2 041 895
Jun 16, 2022 $23.23 $23.92 $22.38 $23.89 1 364 136
Jun 15, 2022 $23.37 $24.86 $23.22 $24.18 1 605 574
Jun 14, 2022 $23.32 $23.78 $22.74 $23.37 822 258
Jun 13, 2022 $23.97 $24.14 $22.55 $23.20 1 420 275
Jun 10, 2022 $24.53 $25.47 $23.97 $25.05 1 101 000
Jun 09, 2022 $25.07 $26.22 $24.97 $25.20 1 106 455
Jun 08, 2022 $24.98 $25.99 $24.67 $25.32 1 068 819
Jun 07, 2022 $23.70 $25.22 $23.54 $25.19 856 233
Jun 06, 2022 $24.66 $25.11 $23.33 $23.83 1 030 786
Jun 03, 2022 $22.81 $24.79 $22.61 $24.75 1 842 927
Jun 02, 2022 $21.75 $23.45 $21.44 $22.99 934 040
Jun 01, 2022 $22.37 $22.64 $20.51 $21.76 1 311 545
May 31, 2022 $23.41 $23.41 $21.99 $22.27 899 758
May 27, 2022 $22.43 $23.44 $21.99 $23.41 1 135 804
May 26, 2022 $21.70 $22.58 $21.57 $22.39 717 246
May 25, 2022 $21.27 $22.12 $20.85 $21.71 804 412
May 24, 2022 $22.11 $22.23 $21.18 $21.41 1 029 998
May 23, 2022 $22.79 $22.91 $21.96 $22.36 989 356
May 20, 2022 $22.12 $23.28 $21.61 $22.79 1 941 201
May 19, 2022 $20.79 $22.90 $20.79 $22.05 2 214 081
May 18, 2022 $20.00 $21.44 $19.83 $20.86 1 499 189
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT